[go: up one dir, main page]

TN2013000094A1 - Manufacturing process for pyrimidine derivatives - Google Patents

Manufacturing process for pyrimidine derivatives

Info

Publication number
TN2013000094A1
TN2013000094A1 TNP2013000094A TN2013000094A TN2013000094A1 TN 2013000094 A1 TN2013000094 A1 TN 2013000094A1 TN P2013000094 A TNP2013000094 A TN P2013000094A TN 2013000094 A TN2013000094 A TN 2013000094A TN 2013000094 A1 TN2013000094 A1 TN 2013000094A1
Authority
TN
Tunisia
Prior art keywords
manufacturing process
pyrimidine derivatives
solid forms
compound
processes
Prior art date
Application number
TNP2013000094A
Other languages
French (fr)
Inventor
John Vincent Calienni
Baoqing Gong
Hui Liu
Maria Caterina Testa
La Cruz Marilyn De
Prasad Koteswara Kapa
Pascal Michel
Liladhar Murlidhar Waykole
Dietmar Flubacher
Piotr H Karpinski
Rasmus Mose
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/053808 external-priority patent/WO2012044727A2/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2013000094A1 publication Critical patent/TN2013000094A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to processes for manufacturing a compound of formula (5) or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of said solid forms for the therapeutic treatment of warm-blooded animals.
TNP2013000094A 2011-09-29 2013-03-08 Manufacturing process for pyrimidine derivatives TN2013000094A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/053808 WO2012044727A2 (en) 2010-10-01 2011-09-29 Manufacturing process for pyrimidine derivatives

Publications (1)

Publication Number Publication Date
TN2013000094A1 true TN2013000094A1 (en) 2014-06-25

Family

ID=54360782

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000094A TN2013000094A1 (en) 2011-09-29 2013-03-08 Manufacturing process for pyrimidine derivatives

Country Status (1)

Country Link
TN (1) TN2013000094A1 (en)

Similar Documents

Publication Publication Date Title
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
PH12016500169A1 (en) Polymorph of syk inhibitors
MY164776A (en) Heterocyclic compound
TN2013000434A1 (en) Novel imidazole derivatives useful for the treatment of arthritis
PH12014500883A1 (en) Uracil derivatives as axl and c-met kinase inhibitors
PH12014501719A1 (en) Pyridone derivatives
MX2015002511A (en) Dihydropyrimidine compounds and their application in pharmaceuticals.
TN2011000404A1 (en) Fused pyrimidines
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
TN2014000058A1 (en) A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes
AU2012204982A8 (en) 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors
MX2013000009A (en) Process for the preparation of the l-arginine salt of perindopril.
MX359069B (en) Salt and crystal forms of plk-4 inhibitor.
MX359399B (en) 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS.
MX350430B (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-m ethyl-pentanoic acid compounds.
MY162945A (en) Azole derivative
TN2013000094A1 (en) Manufacturing process for pyrimidine derivatives
NZ724424A (en) Pyrimidine derivatives for the treatment of bacterial diseases
TN2013000052A1 (en) Oxadiazole inhibitors of leukotriene production
GB2527958A (en) Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
JO3723B1 (en) Heterocyclic compounds
TN2013000122A1 (en) Oxadiazole inhibitors of leukotriene production
TN2014000307A1 (en) Novel morpholinyl derivatives useful as mogat-2 inhibitors
NZ624622A (en) Manufacturing process for pyrimidine derivatives